RxSight RXST
NASDAQ RXST
$5.32 -0.06 (-1.12%)
At close: Nov 13, 2026 · 4:00 PM EST

RxSight (RXST) Current Deferred Revenue (2025 - 2026)

Updated

RxSight (RXST) recorded Current Deferred Revenue of $4.5 million in Q3 2026, down 34.7% from the prior quarter.

Analysis

RxSight (RXST) Current Deferred Revenue (2025 - 2026) Analysis & Trends

At the end of FY2025, RxSight reported Current Deferred Revenue of $3.52 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 RxSight 223.05 Mn -31.65 Mn 18.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.50 Mn
Jun 30, 2026 6.88 Mn
Dec 31, 2025 3.52 Mn
API Access

RxSight Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RXST&period=max&api_key=YOUR_API_KEY